Squarepoint
WST icon

Squarepoint’s West Pharmaceutical WST Stock Holding History

Squarepoint’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,200
Closed -$775K – 4679
2023
Q4 		$775K Sell
2,200
-13,100
-86% -$4.64M ﹤0.01% 2709
2023
Q3 		$5.74M Buy
+15,300
New +$5.92M 0.01% 1083

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Squarepoint's WST Position: Q2 2026 in Review

Squarepoint reduced its West Pharmaceutical (WST) stake by 86% in Q2 2026, selling an estimated $6.22M and leaving 3,313 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

Squarepoint first reported a position in WST in Q2 2016 and has held it in 35 quarters since. The position peaked at $37.7M in Q4 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Squarepoint held 3,313 shares of West Pharmaceutical worth $1.19M as of Q2 2026.
  • Squarepoint sold 20,348 West Pharmaceutical shares in Q2 2026, an estimated $6.22M.
  • West Pharmaceutical made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2771 holding.
  • Squarepoint first reported a position in West Pharmaceutical in Q2 2016 and has held it in 35 quarters since.
  • Squarepoint's West Pharmaceutical position peaked at $37.7M in Q4 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.